Advertisement
investing

Fidelity Select Health Care Portfolio Has a Promising Prognosis

This fund seeks a healthy balance between risk and return.

Health care stocks have climbed steadily over the past decade, even accounting for a pause in 2016, when the sector got entangled in election-year issues. There are reasons to expect the robust returns will continue. Spending on health care around the world is rising, thanks to an aging population in need of specialized care in advanced nations, and a growing middle class in emerging countries seeking better care. What's more, health care spending doesn't wither in the face of rising inflation or interest rates, says Eddie Yoon, manager of Fidelity Select Health Care Portfolio (FSPHX). "Demand is constant," he says.

Yoon typically holds 90 to 100 stocks in Select Health Care, balancing outsize positions in well-established firms with tiny bets in small biotechnology companies that have yet to make their mark. The fund's top holdings, such as insurer and care provider UnitedHealth Group (UNH), are fortress-like stocks that are growing steadily and are run by managers who spend cash wisely. They give the fund stability, says Yoon. The fund's smallest holdings each account for 0.4% or less of assets. These stocks tend to be volatile but have the potential to rise five to 10 times in price, he adds. One holding, biotech firm AC Immune (ACIU), is currently testing treatments for Alzheimer's.

Reader survey
K10I-FUNDTRENDS_RANKINGS.indd

Getty Images

Yoon picks stocks a company at a time. He focuses on free cash flow—the cash that's left over after paying necessary expenses to maintain a business. Price matters. Yoon buys when shares trade at bargain levels based on his forecast of free cash flow per share over the next three to five years.

Advertisement
Advertisement - Article continues below
Advertisement - Article continues below

Select Health Care Portfolio is diversified, but Yoon tilts the fund toward specific areas of the sector that he finds attractive. Shares in health care equipment firms and biotech companies together currently make up 56% of the fund's assets. And he doesn't own stock in Merck or Pfizer these days because he says the big pharmaceutical manufacturers are vulnerable to potential changes in drug-pricing regulations. "Every stock we own is purposeful, and the size in which we own it is purposeful," Yoon says. Since he took over almost 10 years ago, the fund has returned an annualized 17.5%, which beats the MSCI US IMI/Health Care 25-50 index.

Advertisement

Most Popular

What Are the Income Tax Brackets for 2020 vs. 2019?
tax brackets

What Are the Income Tax Brackets for 2020 vs. 2019?

The IRS unveiled the 2020 tax brackets, and it's never too early to start planning to minimize your future tax bill.
June 20, 2020
HSAs Get Even Better
Financial Planning

HSAs Get Even Better

Workers have more options with flexible spending accounts, too.
July 2, 2020
17 States That Will Gain or Lose Electoral-College Votes After the 2020 Census
Politics

17 States That Will Gain or Lose Electoral-College Votes After the 2020 Census

Every 10 years, the 435 seats in the House of Representatives are reassigned based on the results of the U.S.
July 2, 2020

Recommended

HSAs Get Even Better
Financial Planning

HSAs Get Even Better

Workers have more options with flexible spending accounts, too.
July 2, 2020
10 Stocks to Invest in the Health Care Revolution
healthcare stocks

10 Stocks to Invest in the Health Care Revolution

These companies are fighting disease and improving our standard of care.
July 2, 2020
Cash In With This Gaming ETF
Technology

Cash In With This Gaming ETF

Cash in on the video gaming craze with this fund.
July 1, 2020
13 Best Vanguard Funds for the Next Bull Market
mutual funds

13 Best Vanguard Funds for the Next Bull Market

Optimistic that the bounce since March is indeed the start of the next bull market? Here are the 13 best Vanguard funds to help you make the most of i…
June 25, 2020